93 related articles for article (PubMed ID: 26676821)
1. Hepatocellular Carcinoma in Noncirrhotic Liver with Glycogenotic Foci: Basic Science Meets Genomic Medicine.
Lefkowitch JH; Lagana SM; Kato T
Semin Liver Dis; 2015 Nov; 35(4):450-6. PubMed ID: 26676821
[TBL] [Abstract][Full Text] [Related]
2. FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma.
Arao T; Ueshima K; Matsumoto K; Nagai T; Kimura H; Hagiwara S; Sakurai T; Haji S; Kanazawa A; Hidaka H; Iso Y; Kubota K; Shimada M; Utsunomiya T; Hirooka M; Hiasa Y; Toyoki Y; Hakamada K; Yasui K; Kumada T; Toyoda H; Sato S; Hisai H; Kuzuya T; Tsuchiya K; Izumi N; Arii S; Nishio K; Kudo M
Hepatology; 2013 Apr; 57(4):1407-15. PubMed ID: 22890726
[TBL] [Abstract][Full Text] [Related]
3. The Differential Immunohistochemical Expression of p53, c-Jun, c-Myc, and p21 Between HCV-related Hepatocellular Carcinoma With and Without Cirrhosis.
Abdou AG; Abd-Elwahed M; Badr M; Helmy M; Soliman EA; Maher D
Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):75-87. PubMed ID: 25710583
[TBL] [Abstract][Full Text] [Related]
4. Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.
Sonntag R; Giebeler N; Nevzorova YA; Bangen JM; Fahrenkamp D; Lambertz D; Haas U; Hu W; Gassler N; Cubero FJ; Müller-Newen G; Abdallah AT; Weiskirchen R; Ticconi F; Costa IG; Barbacid M; Trautwein C; Liedtke C
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9282-9287. PubMed ID: 30150405
[TBL] [Abstract][Full Text] [Related]
5. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma.
Nishida N; Fukuda Y; Komeda T; Kita R; Sando T; Furukawa M; Amenomori M; Shibagaki I; Nakao K; Ikenaga M
Cancer Res; 1994 Jun; 54(12):3107-10. PubMed ID: 8205525
[TBL] [Abstract][Full Text] [Related]
6. Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: a heuristically highly relevant phenotype.
Bannasch P
World J Gastroenterol; 2012 Dec; 18(46):6701-8. PubMed ID: 23239906
[TBL] [Abstract][Full Text] [Related]
7. Tumor-derived molecular information and outcome in hepatocellular carcinoma.
Hoshida Y
J Hepatol; 2009 Sep; 51(3):595-6; author reply 596-7. PubMed ID: 19586677
[No Abstract] [Full Text] [Related]
8. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
Ritorto MS; Borlak J
J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells.
Zhang X; Hu S; Zhang X; Wang L; Zhang X; Yan B; Zhao J; Yang A; Zhang R
Biochem Biophys Res Commun; 2014 Jan; 443(3):1078-84. PubMed ID: 24370822
[TBL] [Abstract][Full Text] [Related]
10. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.
Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T
Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283
[TBL] [Abstract][Full Text] [Related]
11. [Study on the expression of oncogene mRNA in hepatocellular carcinoma using in situ hybridization technique].
Hayashi D
Nihon Geka Gakkai Zasshi; 1994 Nov; 95(11):814-22. PubMed ID: 7830708
[TBL] [Abstract][Full Text] [Related]
12. The Clinicopathologic Significance of BAF250a (ARID1A) Expression in Hepatocellular Carcinoma.
Zhao J; Chen J; Lin H; Jin R; Liu J; Liu X; Meng N; Cai X
Pathol Oncol Res; 2016 Jul; 22(3):453-9. PubMed ID: 26589513
[TBL] [Abstract][Full Text] [Related]
13. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
14. Liver adenomas in glycogen storage disease in children. Ultrasound and angiographic study.
Brunelle F; Tammam S; Odievre M; Chaumont P
Pediatr Radiol; 1984; 14(2):94-101. PubMed ID: 6328402
[TBL] [Abstract][Full Text] [Related]
15. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis.
Poon RT; Fan ST; Lo CM; Liu CL; Ng IO; Wong J
J Clin Oncol; 2000 Mar; 18(5):1094-101. PubMed ID: 10694562
[TBL] [Abstract][Full Text] [Related]
16. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
Ji F; Zhang ZH; Zhang Y; Shen SL; Cao QH; Zhang LJ; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2018 Apr; 18(1):460. PubMed ID: 29690860
[TBL] [Abstract][Full Text] [Related]
17. Clear cell hepatocellular carcinoma: origin, metabolic traits and fate of glycogenotic clear and ground glass cells.
Bannasch P; Ribback S; Su Q; Mayer D
Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):570-594. PubMed ID: 29291777
[TBL] [Abstract][Full Text] [Related]
18. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.
Nault JC; Datta S; Imbeaud S; Franconi A; Mallet M; Couchy G; Letouzé E; Pilati C; Verret B; Blanc JF; Balabaud C; Calderaro J; Laurent A; Letexier M; Bioulac-Sage P; Calvo F; Zucman-Rossi J
Nat Genet; 2015 Oct; 47(10):1187-93. PubMed ID: 26301494
[TBL] [Abstract][Full Text] [Related]
19. Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non-BRCAness high grade ovarian carcinoma.
Goundiam O; Gestraud P; Popova T; De la Motte Rouge T; Fourchotte V; Gentien D; Hupé P; Becette V; Houdayer C; Roman-Roman S; Stern MH; Sastre-Garau X
Int J Cancer; 2015 Oct; 137(8):1890-900. PubMed ID: 25892415
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma.
He F; Li J; Xu J; Zhang S; Xu Y; Zhao W; Yin Z; Wang X
J Exp Clin Cancer Res; 2015 May; 34(1):47. PubMed ID: 25975202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
